Lymphangioleiomyomatosis

MANAGEMENT³

Mammalian target of rapamycin (mTOR) inhibitors can stabilize or slow decline in pulmonary function in patients who have progressive disease, with FEV₁ <70%
Lung transplantation

See also

Test your knowledge

Bridging gaps in ILD education image

Bridging educational gaps in ILD

Interstitial lung disease in systemic sclerosis with a focus on chest CT

Media library